The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China ...Middle East

The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was significantly greater than that in the placebo group, of which the difference was...

Read More Details
Finally We wish PressBee provided you with enough information of ( The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China )

Also on site :

• India-Pakistan deadly fighting forces airlines to re-route, cancel flights
• Kremlin comments on ceasefire plans after Ukrainian drone strikes
• '90s Singer Makes Powerful Career Move After 5 Years Without New Music